| 11/19/2026 4:00 PM | Lisata Therapeutics (320017) Filer | Form S-3/A | |
| 11/19/2026 3:12 PM | Lisata Therapeutics (320017) Filer | Form 8-K/A | |
| 11/19/2026 8:18 AM | Lisata Therapeutics (320017) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/12/2026 4:13 PM | Lisata Therapeutics (320017) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 11/12/2026 4:16 PM | Lisata Therapeutics (320017) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 11/12/2026 5:07 AM | Lisata Therapeutics (320017) Filer | Form 8-K/A | |
| 11/09/2026 4:15 PM | Lisata Therapeutics (320017) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/09/2026 4:19 PM | Lisata Therapeutics (320017) Filer | Form DEFA14A | |
| 10/19/2026 7:55 AM | Lisata Therapeutics (320017) Filer | Form ARS | |
| 10/19/2026 5:38 AM | Lisata Therapeutics (320017) Filer | Form DEF 14A | |
| 10/15/2026 7:44 PM | Farrow Jeffrey S (1405253) Reporting Lisata Therapeutics (320017) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for LSTA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lisata Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/14/2026 3:25 PM | Lisata Therapeutics (320017) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/07/2026 4:17 PM | Lisata Therapeutics (320017) Filer | Form PRE 14A | |
| 09/28/2026 8:29 PM | Lehrer-Graiwer Joshua (1789673) Reporting Lisata Therapeutics (320017) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 09/28/2026 8:30 PM | Lisata Therapeutics (320017) Issuer LOVE TED W (1188919) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 09/17/2026 8:27 AM | Lisata Therapeutics (320017) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/26/2026 12:02 PM | Branham Justin Earl (2150037) Filed by Lisata Therapeutics (320017) Subject | Form SCHEDULE 13G | |
| 08/06/2026 3:03 PM | Lisata Therapeutics (320017) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/04/2026 5:01 AM | Lisata Therapeutics (320017) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/21/2026 5:00 AM | Lisata Therapeutics (320017) Subject | Form SC 14D9/A | |
| 07/17/2026 5:56 AM | Lisata Therapeutics (320017) Subject | Form SC 14D9/A | |
| 07/17/2026 6:01 AM | Lisata Therapeutics (320017) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/17/2026 5:01 AM | Kuva Labs, Inc. (2117902) Filed by Lisata Therapeutics (320017) Subject | Form SC TO-T/A | |
| 07/13/2026 5:02 AM | Lisata Therapeutics (320017) Subject | Form SC 14D9/A | |
| 07/10/2026 4:20 PM | Kuva Labs, Inc. (2117902) Filed by Lisata Therapeutics (320017) Subject | Form SC TO-T/A | |
| 07/02/2026 3:06 PM | Lisata Therapeutics (320017) Subject | Form SC 14D9/A | |
| 06/10/2026 7:38 AM | Lisata Therapeutics (320017) Subject | Form SC 14D9 | |
| 06/10/2026 7:03 AM | Kuva Labs, Inc. (2117902) Filed by Lisata Therapeutics (320017) Subject | Form SC TO-T | |
| 06/09/2026 6:30 AM | Lisata Therapeutics (320017) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/09/2026 6:31 AM | Lisata Therapeutics (320017) Subject | Form SC14D9C | |
| 06/01/2026 7:08 AM | Kuva Labs, Inc. (2117902) Filed by Lisata Therapeutics (320017) Subject | Form SC TO-C | |
| 06/01/2026 5:09 AM | Lisata Therapeutics (320017) Subject | Form SC14D9C | |
| 06/01/2026 5:03 AM | Lisata Therapeutics (320017) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/29/2026 4:28 PM | Kuva Labs, Inc. (2117902) Filed by Lisata Therapeutics (320017) Subject | Form SC TO-C | |
| 05/29/2026 3:59 PM | Lisata Therapeutics (320017) Subject | Form SC14D9C | |
| 05/29/2026 3:50 PM | Lisata Therapeutics (320017) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/11/2026 3:03 PM | Lisata Therapeutics (320017) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/04/2026 9:42 AM | Kuva Labs, Inc. (2117902) Filed by Lisata Therapeutics (320017) Subject | Form SC TO-C | |
| 05/04/2026 5:04 AM | Lisata Therapeutics (320017) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/04/2026 5:04 AM | Lisata Therapeutics (320017) Subject | Form SC14D9C | |
| 04/28/2026 3:03 PM | Lisata Therapeutics (320017) Filer | Form 10-K/A | |
Financial legend: “This is bad, really bad...” (Ad) Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leading Weiss Ratings, the only conflict-free rating agency in the US.
Now he says a $3 trillion problem could trigger a chain reaction of crashes and failures, causing a global freeze in financial markets. See Dr. Weiss's full warning before the next crisis hits. |
| 04/15/2026 3:01 PM | Lisata Therapeutics (320017) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/15/2026 3:03 PM | Lisata Therapeutics (320017) Subject | Form SC14D9C | |
| 03/09/2026 8:03 AM | Lisata Therapeutics (320017) Subject | Form SC14D9C | |
| 03/09/2026 6:39 AM | Lisata Therapeutics (320017) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/27/2026 7:27 AM | Lisata Therapeutics (320017) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/21/2026 8:19 AM | Lisata Therapeutics (320017) Subject | Form SC14D9C | |
| 01/21/2026 7:58 AM | Lisata Therapeutics (320017) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/13/2026 3:07 PM | Buck Kristen K (1879231) Reporting Lisata Therapeutics (320017) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 3:08 PM | Imam Tariq (2055011) Reporting Lisata Therapeutics (320017) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 3:08 PM | Lisata Therapeutics (320017) Issuer Nisco James (2020260) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 3:09 PM | Lisata Therapeutics (320017) Issuer Mazzo David J (1334549) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 3:02 PM | AZAB MOHAMMAD (1309653) Reporting Lisata Therapeutics (320017) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 3:03 PM | BROWN GREGORY B (1373585) Reporting Lisata Therapeutics (320017) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 3:04 PM | Flowers Cynthia Louise (1741455) Reporting Lisata Therapeutics (320017) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 3:05 PM | HENSON HEIDI (1283301) Reporting Lisata Therapeutics (320017) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 3:06 PM | KLOSK STEVEN M (1192621) Reporting Lisata Therapeutics (320017) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |